CRSP logo

CRISPR Therapeutics AG (CRSP) Current Assets

Annual Current Assets

$1.91 B
+$55.05 M+2.97%

31 December 2023

CRSP Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$1.94 B
-$66.52 M-3.31%

30 September 2024

CRSP Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRSP Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.0%+10.4%
3 y3 years+11.2%-22.8%
5 y5 years+309.1%+192.7%

CRSP Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-21.1%+11.2%-22.8%+10.4%
5 y5 years-21.1%+309.1%-25.8%+192.7%
alltimeall time-21.1%>+9999.0%-25.8%+1139.4%

CRISPR Therapeutics AG Current Assets History

DateAnnualQuarterly
Sept 2024
-
$1.94 B(-3.3%)
June 2024
-
$2.01 B(-5.2%)
Mar 2024
-
$2.12 B(+11.1%)
Dec 2023
$321.49 M(-17.6%)
$1.91 B(+8.4%)
Sept 2023
-
$1.76 B(-5.3%)
June 2023
-
$1.86 B(-2.5%)
Mar 2023
-
$1.91 B(+3.0%)
Dec 2022
$390.03 M(+16.6%)
$1.85 B(-4.1%)
Sept 2022
-
$1.93 B(-8.3%)
June 2022
-
$2.11 B(-6.8%)
Mar 2022
-
$2.26 B(-6.5%)
Dec 2021
$334.36 M(+200.3%)
$2.42 B(-4.0%)
Sept 2021
-
$2.52 B(-3.9%)
June 2021
-
$2.62 B(+43.0%)
Mar 2021
-
$1.83 B(+6.7%)
Dec 2020
$111.35 M
$1.72 B(+23.4%)
Sept 2020
-
$1.39 B(+44.0%)
June 2020
-
$965.62 M(+3.9%)
DateAnnualQuarterly
Mar 2020
-
$929.28 M(-5.9%)
Dec 2019
$79.20 M(+250.1%)
$987.55 M(+48.7%)
Sept 2019
-
$664.07 M(+51.4%)
June 2019
-
$438.47 M(-2.5%)
Mar 2019
-
$449.80 M(-3.6%)
Dec 2018
$22.62 M(-1.5%)
$466.39 M(-6.1%)
Sept 2018
-
$496.69 M(+50.3%)
June 2018
-
$330.55 M(-6.0%)
Mar 2018
-
$351.48 M(+41.5%)
Dec 2017
$22.96 M(-7.3%)
$248.38 M(-3.9%)
Sept 2017
-
$258.59 M(-8.1%)
June 2017
-
$281.29 M(-5.1%)
Mar 2017
-
$296.46 M(-7.4%)
Dec 2016
$24.77 M(+859.1%)
$320.19 M(+38.2%)
Sept 2016
-
$231.65 M(-7.0%)
June 2016
-
$249.16 M(+58.9%)
Dec 2015
$2.58 M(+362.1%)
$156.84 M
Dec 2014
$559.00 K
-

FAQ

  • What is CRISPR Therapeutics AG annual total current assets?
  • What is the all time high annual current assets for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual current assets year-on-year change?
  • What is CRISPR Therapeutics AG quarterly total current assets?
  • What is the all time high quarterly current assets for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG quarterly current assets year-on-year change?

What is CRISPR Therapeutics AG annual total current assets?

The current annual current assets of CRSP is $1.91 B

What is the all time high annual current assets for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual total current assets is $2.42 B

What is CRISPR Therapeutics AG annual current assets year-on-year change?

Over the past year, CRSP annual total current assets has changed by +$55.05 M (+2.97%)

What is CRISPR Therapeutics AG quarterly total current assets?

The current quarterly current assets of CRSP is $1.94 B

What is the all time high quarterly current assets for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly total current assets is $2.62 B

What is CRISPR Therapeutics AG quarterly current assets year-on-year change?

Over the past year, CRSP quarterly total current assets has changed by +$183.31 M (+10.41%)